The Acute Treatment Response Test
Escapee cancer cells in the blood, or ‘CTCs’ as they are known, can be found by a simple blood test. A CTC Count test finds escapee cancer cells (CTCs) in a blood sample and counts them. The Acute Treatment Response test is a short series of two-three CTC counts taken before, during, and immediately after chemotherapy treatment.
The immediate effect of chemotherapy on CTCs can now be measured. The Maintrac® Acute Treatment Response test can be used to:
- Assess the immediate effects of therapies especially chemotherapy on a person’s CTCs
- Monitor the acute treatment stage closely
- Have confidence in the chosen treatment
Maintrac® is a state-of-the-art German technology that detects, characterises and tests CTCs. It has been critically validated and published in peer reviewed journals for over 12 years. Maintrac® CTC tests are acknowledged and utilised by many universities, Oncologists and cancer clinics worldwide.
The best way to monitor cancer activity and long-term effectiveness of treatment is via a single CTC count test every 3-6 months.